Monopar Therapeutics
Annual report (10-K)
Latest 10-K/A filed Apr 1, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Monopar Therapeutics
| Name | Roles | Filings |
|---|---|---|
| Anderson Raymond | Director | 11 |
| Brown Michael J | Director | 11 |
| Mazar Andrew Paul | OfficerDirector | 6 |
| Rioux Patrice | - | 5 |
| Vu Quan Anh | Officer | 3 |
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Monopar Therapeutics. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Robinson Chandler | 3 | 67% | -39.0% | +3.5% | +12.9% | -133.4% |
| 2 | Cittadine Andrew | 10 | 20% | -19.6% | -22.5% | +17.1% | -47.5% |
All filings
128 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|